HMP Global August 1, 2022
Widespread adoption of telehealth during the COVID-19 pandemic has kept more veterans with opioid addiction engaged in medication-assisted treatment (MAT), according to a new study by the University of Michigan and VA Ann Arbor Healthcare System.
Findings were published in the American Journal of Psychiatry.
The study covered veterans who received buprenorphine to treat opioid use disorder (OUD) before and after care visits were shifted to phone and video platforms as a result of the pandemic in early 2020. For all of 2020, phone-only visits outpaced both video and in-person visits. By early 2021, phone visits accounted for about half of all buprenorphine-related engagements with providers, compared to video-based (32%) and in-person (17%) visits.
Furthermore, while the total number of...